Despite Original skepticism, new advancements in peptide drug discovery have rejuvenated curiosity in peptides as therapeutic brokers, with about 70 peptides now marketed and several others in clinical development.Clinical trials and preclinical studies are highlighted, demonstrating the efficacy of peptide vaccines in inducing an immune response,